Unusual Cutaneous Reaction with Erlotinib: A Brief Report with Current Review of Management of Tyrosine Kinase Inhibitor-associated Cutaneous Toxicity

Unusual Cutaneous Reaction with Erlotinib: A Brief Report with Current Review of Management of Tyrosine Kinase Inhibitor-associated Cutaneous Toxicity

Tyrosine kinase inhibitors (TKIs) have emerged as the preferred choice of treatment for various tumors as a result of better outcomes and quality of life without the debilitating side effects of cytotoxic chemotherapy. Erlotinib is a TKI against epidermal growth factor receptor that is commonly used...

Full description

Saved in:
Bibliographic Details
Main Authors: Aashita, Vikas Yadav, Pragyat Thakur, Anuja Kapoor
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Journal of Radiation and Cancer Research
Subjects:
acneiform rash
cutaneous side effect
epidermal growth factor receptor inhibitor
erlotinib
Online Access:https://journals.lww.com/10.4103/jrcr.jrcr_12_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items